TREY PERKINS: Open Payments
NPI 1851925267 · GOODLETTSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 62 payments from 14 companies in 2025. Trend: 2023 $119 · 2024 $1,008 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $295 |
| E.R. Squibb & Sons, L.L.C. | 6 | $176 |
| Otsuka America Pharmaceutical, Inc. | 9 | $157 |
| Alkermes, Inc. | 6 | $120 |
| Axsome Therapeutics, Inc. | 12 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| ABBVIE INC. | 4 | $77 |
| Noven Therapeutics, LLC | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
Products named: FANAPT, COBENFY, ARISTADA, Auvelity, REXULTI, HETLIOZ, CAPLYTA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
